• Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg

    Source: NASDAQ US Markets / 14 Jan 2025 07:49:06   America/Chicago

    (RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal spray 8 mg in the U.S. and Canada. https://www.nasdaq.com/articles/hikma-pharma-inks-exclusive-commercial-deal-emergent-biosolutions-kloxxado-nasal-spray-8
Share on,